Search results for "Renal Insufficiency"

showing 10 items of 175 documents

Is echocardiography mandatory for patients with chronic kidney disease?

2019

This study aims at evaluating the prevalence of left ventricular diastolic dysfunction in a group of 319 hypertensive patients with stage 3b–4–5 chronic kidney disease (according to Kidney Disease Improving Global Outcomes classification), compared with 216 patients with essential hypertension and normal renal function. All patients underwent echocardiographic examination. Patients on stage 1–2–3a chronic kidney disease, dialysis treatment, or with previous manifestations of heart failure or other cardiovascular diseases were excluded. Patients with renal disease had significantly worse diastolic function (both considering trans-mitral flow and tissue Doppler imaging parameters). Diastolic …

Malemedicine.medical_specialtyDiastolic functionmedicine.medical_treatmentPopulationRenal functionHeart failure030204 cardiovascular system & hematologyEssential hypertensionAsymptomatic03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineInternal medicineChronic kidney diseaseInternal MedicinemedicinePrevalenceHumans030212 general & internal medicineRenal Insufficiency ChroniceducationDialysisAgededucation.field_of_studyAnalysis of Variancebusiness.industryDiagnostic Tests RoutineDiastolic heart failureMiddle Agedmedicine.diseaseEchocardiographyHeart failureHypertensionEmergency MedicineCardiologyFemalemedicine.symptombusinessKidney diseaseInternal and emergency medicine
researchProduct

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

2020

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease. Its role in the development of extrahepatic co-morbidities is under investigation. The impact of NAFLD on the development of chronic kidney disease (CKD) is incompletely understood. The aim of this study was to explore the potential contribution of NAFLD on CKD in Germany. METHODS: The Disease Analyzer Database covering 7.49 million cases in Germany was explored for patients diagnosed with NAFLD between 2000 and 2015 and was matched 1:1 to a cohort without NAFLD. Matching criteria included age, sex, physician, index year and co-diagnoses associated with CKD. The primary outcomes of thi…

Malemedicine.medical_specialtyDiseaseComorbidityChronic liver diseaseGastroenterologydigestive systemNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineGermanymedicineHumansRenal Insufficiency ChronicDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective Studiesbusiness.industryIncidenceFatty liverGastroenterologynutritional and metabolic diseasesNon alcoholicMiddle Agedmedicine.diseasedigestive system diseasesOncologyFemaleHepatobiliaryMetabolic syndromebusinessAnxiety disorderKidney disease
researchProduct

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).

2012

To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high-risk patients.Patients with chronic kidney disease (CKD) scheduled for MRI procedures were screened. The primary endpoint was the percentage of patients with an elevation of serum creatinine levels, measured 72 ± 24 h after the MRI procedure, by at least 25 % or 44.2 μmol/l (0.5 mg/dl) from baseline. A non-inferiority margin of the between-group difference was set at -15 % for statistical analysis of the primary endpoint. Main secondary endpoints were the variation in serum creatinine and eGFR values between baseline and 72 ± 24 h …

Malemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsContrast MediaNephrogenic Fibrosing DermopathyHeterocyclic CompoundsRisk FactorsOrganometallic CompoundsPrevalenceMedicineHumansRadiology Nuclear Medicine and imagingRenal Insufficiency ChronicneoplasmsNeuroradiologyAgedmedicine.diagnostic_testMegluminebusiness.industryAcute kidney injuryMagnetic resonance imagingInterventional radiologyGeneral MedicineAcute Kidney Injurymedicine.diseaseMagnetic Resonance ImagingEuropeTreatment OutcomeRadiology Nuclear Medicine and imagingNephrogenic systemic fibrosisAngiographyFemaleRadiologybusinessmedicine.drugKidney diseaseEuropean radiology
researchProduct

Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency

2017

Purpose Patients with growth hormone deficiency (GHD) demonstrate an increased cortisol/cortisone ratio which could potentially explain the metabolic features of GHD, while GH treatment (GHT) could increase the cortisol metabolism. Methods In 35 children (27 M, mean age 10.1 years) with idiopathic GHD at baseline and after 12 months of GHT and in 25 controls, in addition to metabolic parameters, we assessed adrenal function by morning serum cortisol, its peak, and its area under the curve (AUCCOR) during insulin tolerance test (ITT). Results A cortisol peak <18 µg/dl was shown in 22 and 31% of GHD children at baseline and after GHT, respectively. At baseline, GHD children had lower fasting …

Malemedicine.medical_specialtyGHD adrenal insufficiencyCortisol awakening responseHydrocortisoneEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismSettore MED/13 - EndocrinologiaGrowth hormone deficiency03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceInternal medicineAdrenal GlandsmedicineHumansProspective Studies030212 general & internal medicineChildDwarfism PituitaryMorningHydrocortisoneHuman Growth Hormonebusiness.industryInsulin tolerance testPrognosismedicine.diseaseGrowth hormone secretionEndocrinologyCase-Control StudiesChild PreschoolFemaleAdrenal Cortex Function TestsInsulin ResistanceCortisonebusinessBiomarkershormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugJournal of Endocrinological Investigation
researchProduct

Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease.

2010

Left ventricular hypertrophy (LVH) and diastolic dysfunction are very common in patients with chronic kidney disease (CKD). Aim of this study was to evaluate the impact of type 2 diabetes on LV geometry and diastolic function in hypertensive patients with CKD. We enrolled 288 Caucasian subjects with hypertension and CKD; of them, 112 had diabetes. Patients with cardiovascular (CV) diseases, glomerular filtration rate (GFR)60 ml min(-1) per 1.73 m(2), dialysis treatment and other major non-CV diseases were excluded. All patients underwent routine biochemical analyses and echocardiographic examination with tissue Doppler imaging (TDI). Patients with diabetes had significantly higher LV wall t…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentRenal functionType 2 diabetesComorbidityLeft ventricular hypertrophyInternal medicineDiabetes mellitusInternal MedicinemedicinePrevalenceHumansRenal Insufficiency ChronicDialysisAgedUltrasonographyheart diseasesVentricular Remodelingbusiness.industryMiddle Agedmedicine.diseaseleft ventricular hypertrophySurgeryBlood pressureDiabetes Mellitus Type 2diabeteHypertensionCardiologydiastolic dysfunctionFemaleHypertrophy Left Ventricularbusinesschronic kidney diseaseKidney diseaseGlomerular Filtration RateJournal of human hypertension
researchProduct

Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.

2021

Abstract Background Hyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that is associated with a higher risk of adverse clinical events such as ventricular arrhythmias and sudden cardiac death. Currently, data regarding the prognostic implications of chronic hyperkalaemia are available; however, information about the long-term clinical consequences after an episode of severe hyperkalaemia remains scarce. The objective of this study was to evaluate the association between the trajectory of potassium measurements in patients with acu…

Malemedicine.medical_specialtyHyperkalemiaAftercareSudden cardiac deathInternal medicineDiabetes mellitusmedicineRisk of mortalityHumansRenal Insufficiency ChronicAgedAged 80 and overTransplantationbusiness.industrySang Coagulació FactorsRetrospective cohort studymedicine.diseasePatient DischargeNephrologyHeart failureCardiologyInsuficiència renal crònicaPotassiumHyperkalemiamedicine.symptomComplicationbusinessKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair.

2020

BACKGROUND In catheter-based procedures, acute kidney injury (AKI) is a frequent, serious complication ranging from 10% to 30%. In MitraClip (Abbott Vascular, Santa Clara, California), a usually contrast-free procedure, there is scarce data about its real incidence and impact. OBJECTIVES This study aimed to evaluate incidence, predictive factors, and midterm outcomes of AKI in patients with significant mitral regurgitation (MR) undergoing transcatheter valve repair with MitraClip. METHODS A total of 721 patients undergoing MitraClip were included. AKI was defined as an absolute or a relative increase in serum creatinine of >0.3 mg/dl or >= 50%, respectively, or the need for hemodialysis dur…

Malemedicine.medical_specialtyMitral Valve Annuloplastymedicine.medical_treatmentPopulationRenal function030204 cardiovascular system & hematologyoutcomesurologic and male genital diseasesrenal insufficiency03 medical and health sciences0302 clinical medicinePostoperative ComplicationsInterquartile rangeInternal medicinemedicineMitraClipHumans030212 general & internal medicinemitral edge-to-edge repaireducationAgedRetrospective StudiesAged 80 and overMitral regurgitationeducation.field_of_studybusiness.industryMitraClipIncidenceEndovascular ProceduresAcute kidney injuryMitral Valve InsufficiencyAcute Kidney InjuryMiddle AgedMitraClip acute kidney injury mitral edge-to-edge repair mortality outcomes renal insufficiencymedicine.diseasemortalityfemale genital diseases and pregnancy complicationsacute kidney injurySpainCardiologyFemaleHemodialysisCardiology and Cardiovascular MedicineComplicationbusiness
researchProduct

Comparison of N-terminal proB-type natriuretic peptide levels at different stages of visceral leishmaniosis and in patients with chronic kidney disea…

2018

N-terminal proB-type natriuretic peptide (NT-proBNP) may be a useful marker in canine leishmaniosis (CanL). The aim was to compare NT-proBNP in dogs at different LeishVet stages of CanL and with idiopathic chronic kidney disease (CKD). Dogs diagnosed with CanL or CKD and a group of healthy dogs were included (group A, five normal dogs; group B, six dogs LeishVet 1-2; group C, 13 dogs LeishVet 3-4; group D, six dogs with CKD). NT-proBNP was higher (P0.001) in group C (7.616 pmol/l, interquartile range (IQR) 3537-10,000 pmol/l) than in group A (293 pmol/l, IQR 257-373), group B (388.5 pmol/l, IQR 324-793) and group D (740 pmol/l, IQR 557-962 pmol/l). International Renal Interest Society (IRIS…

Malemedicine.medical_specialtyMyocarditisN-Terminal ProB-type Natriuretic Peptide040301 veterinary sciencesmedicine.drug_classLeft ventricular hypertrophyGastroenterologyGroup A0403 veterinary scienceDogsInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideAnimalsHumansIn patientcardiovascular diseasesDog DiseasesRenal Insufficiency ChronicGeneral Veterinarybusiness.industry0402 animal and dairy science04 agricultural and veterinary sciencesGeneral Medicinemedicine.disease040201 dairy & animal sciencePeptide FragmentsLeishmaniasis VisceralFemalebusinesshormones hormone substitutes and hormone antagonistsBiomarkersKidney diseaseThe Veterinary record
researchProduct

Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency

1997

A 7-year-old male with recurrent erythematous and desquamated skin lesions and respiratory infections was diagnosed as selective complete C1q deficiency following detailed studies of the complement system. His asymptomatic sister also had selective complete C1q deficiency. During a follow up period of 3 years, his skin lesions persisted, he suffered from recurrent bronchopneumonias and glomerulonephritis developed. Renal function deteriorated with the appearance of anti-DNA antibodies. Renal biopsy was consistent with systemic lupus erythematosus. The patient was treated with immunosuppressive drugs, but died of renal failure. It is postulated that in this patient defective clearance of ant…

Malemedicine.medical_specialtyPathologyBlood Protein DisordersRenal functionDiseaseAsymptomaticFatal OutcomemedicineHumansLupus Erythematosus SystemicPoint MutationRenal InsufficiencyChildLupus erythematosusmedicine.diagnostic_testbusiness.industryComplement C1qGlomerulonephritismedicine.diseaseDermatologyComplement systemPediatrics Perinatology and Child HealthRenal biopsymedicine.symptombusinessMalar rashEuropean Journal of Pediatrics
researchProduct

Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pres…

2019

OBJECTIVE: Hyperuricemia has been associated with high blood pressure (BP) values, diabetes mellitus, metabolic syndrome and chronic kidney disease (CKD). In the present study, we assessed the gender-related relationships between serum uric acid (SUA) and cardionephrometabolic variables in central and east European hypertensive patients. METHODS: A total of 3206 treated hypertensive patients with available SUA levels from the BP-CARE study was analyzed. Correlations among SUA, BP values, BP control, diabetes mellitus, metabolic syndrome and CKD were performed according to gender. RESULTS: Twenty-five percent of the whole population showed hyperuricemia (28% in women and 23% in men). These p…

Malemedicine.medical_specialtyPhysiologyCross-sectional studyBlood PressureComorbidityHyperuricemia030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex FactorsRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineDiabetes MellitusPrevalenceHumans030212 general & internal medicineHyperuricemiaEurope EasternRenal Insufficiency ChronicAgedMetabolic Syndromebusiness.industrynutritional and metabolic diseasesMiddle AgedCardiovascular riskKidney damagemedicine.diseaseComorbidityUric AcidBlood pressureCross-Sectional StudieschemistryHypertensionUric acidFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of hypertension
researchProduct